Rebalix
iShares · sheet of 10 September 2026
iShares · sheet of 10 September 2026ETF sheet · official issuer and register data
iShares Global Inflation Linked Govt Bond UCITS ETF
IGIL · IE00B3B8PX14 · USD · domicile Ireland
Bonds · Inflation-linked USD · Broad (all maturities) · GlobalSFDR art. 6
Index tracked: BBG World Government Inflation-Linked Bond Index (USD)
- TER
- 0.20%+ trans. 0.02%
- Fund size
- 449 m EUR
- Tracking difference
- −0.17%3-year avg
- 🇮🇹 tax rate
- 12.75%white list 98.12%
- Replication
- Physical (optimised)
- Income
- Accumulating
- Duration
- 8.10 yrslong (>7 years)
Launch 1 Aug 2008 · costs from the KID as of 2 Sept 2026 · 154 securities held · 8 venues (ESMA register)
The fund’s objective — in the issuer’s words
From the Key Information Document (KID) · 4 Aug 2026
The Share Class is a share class of a Fund which aims to achieve a return on your investment, through a combination of capital growth and income on the Fund’s assets, which reflects the return of the Bloomberg World Government Inflation-Linked Bond Index, the Fund’s benchmark index (Index). The Share Class, via the Fund is passively managed and aims to invest so far as possible and practicable in inflation-linked fixed income (FI) securities (such as bonds and other debt securities which pay income which is linked to a rate of inflation) that make up the…
Performance since series start (in euro) — base 100
1 Aug 2008 → 31 Aug 2026 · dividends reinvested where declared by the issuer · converted at ECB rates
Returns in euro
| 1 year | +2.3% |
| 3 years | +2.7% |
| 5 years | −12.8% |
| 10 years | +2.1% |
| Since series start | +76.1% |
Risk · 1 / 3 / 5 years
| Volatility (ann.) | 4.96% | 6.35% | 8.75% |
| Max drawdown | −3.47% | −8.59% | −30.88% |
| Sharpe | -0.22 | 0.10 | -0.58 |
| Sortino | -0.30 | 0.15 | -0.79 |
Sharpe/Sortino: risk-free = ECB MRO avg; nominal volatility
Rebalix · IGIL · IE00B3B8PX141
RebalixIGIL · IE00B3B8PX14 · sheet of 10 September 2026
Tracking difference — year by year
Fund minus index, complete calendar years · from issuer-declared series
| Year | Fund | Index | TD |
|---|---|---|---|
| 2025 | +8.64% | +8.79% | −0.15% |
| 2024 | −3.27% | −3.10% | −0.16% |
| 2023 | +5.28% | +5.48% | −0.20% |
| 2022 | −22.02% | −21.85% | −0.17% |
| 2021 | +2.92% | +3.12% | −0.20% |
Fixed income — as declared by the issuer
Issuer page · 20 Aug 2026 · investment-grade share (BBB−/Baa3 and above): 99.6%
Rating breakdown (% of fund)
Maturity breakdown (% of fund)
Holdings
Portfolio as declared by the issuer · 31 Aug 2026 · 154 securities · top-10 weight = 16.4%
Countries (% of fund)
Sectors (% of fund)
Listing venues
ESMA register (FIRDS) and official exchange lists
IUS5 · Börse Düsseldorf, Börse Frankfurt, Börse Hamburg, Börse Hannover, Börse München / gettex, Börse Stuttgart, Tradegate Exchange, Xetra (Deutsche Börse)
+ 6 unmapped venues (MTF, RFQ, professional)
Official documents
Clickable links in the PDF
The live sheet, always up to date
rebalix.com/en/etf/IE00B3B8PX14
Series, distributions, holdings and documents refresh daily.
rebalix.com/en/etf/IE00B3B8PX14
Series, distributions, holdings and documents refresh daily.
Sheet produced on 10 September 2026 · data as of the dates shown section by section. Sources: official issuer documents (KID, factsheet, NAV and total-return series, declared portfolio), ESMA register (FIRDS), European Central Bank (FX), Italian tax authority / issuer (white-list share). Public methodology: rebalix.com/en/methodology. “—” = not published by the source, never estimated.
Informational document generated by rebalix.com: facts only, no recommendations. Not investment advice or investment research under Directive 2014/65/EU (MiFID II), nor an offer or solicitation. Past performance is not indicative of, nor a guarantee of, future results; the value of an investment can go down as well as up. Before any decision read the issuer’s KID and Prospectus; tax treatment depends on individual circumstances. Trademarks and logos belong to their respective owners and only identify the instrument and its issuer: no affiliation, sponsorship or endorsement.
Rebalix · IGIL · IE00B3B8PX142